These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Coen M; Holmes E; Lindon JC; Nicholson JK Chem Res Toxicol; 2008 Jan; 21(1):9-27. PubMed ID: 18171018 [TBL] [Abstract][Full Text] [Related]
3. Biomarker discovery and related topics. Guttman A Electrophoresis; 2009 Apr; 30(7):1095. PubMed ID: 19373802 [No Abstract] [Full Text] [Related]
4. Discovery and development of biomarkers of neurological disease. Dunckley T; Coon KD; Stephan DA Drug Discov Today; 2005 Mar; 10(5):326-34. PubMed ID: 15749281 [TBL] [Abstract][Full Text] [Related]
5. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics. Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361 [TBL] [Abstract][Full Text] [Related]
6. Biomarker discovery and related topics. Guttman A; Takacs L Electrophoresis; 2007 Dec; 28(23):4259. PubMed ID: 18041041 [No Abstract] [Full Text] [Related]
7. Biomarker discovery using molecular profiling approaches. Walker SJ; Xu A Int Rev Neurobiol; 2004; 61():1-30. PubMed ID: 15482809 [No Abstract] [Full Text] [Related]
8. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Beckonert O; Keun HC; Ebbels TM; Bundy J; Holmes E; Lindon JC; Nicholson JK Nat Protoc; 2007; 2(11):2692-703. PubMed ID: 18007604 [TBL] [Abstract][Full Text] [Related]
9. Interpretation of large-scale quantitative shotgun proteomic profiles for biomarker discovery. Isserlin R; Emili A Curr Opin Mol Ther; 2008 Jun; 10(3):231-42. PubMed ID: 18535930 [TBL] [Abstract][Full Text] [Related]
10. Cell surface biomarkers of embryonic stem cells. Nagano K; Yoshida Y; Isobe T Proteomics; 2008 Oct; 8(19):4025-35. PubMed ID: 18763704 [TBL] [Abstract][Full Text] [Related]
11. Biomarker discovery: validation and decision-making in product development. Niedbala RS; Mauck C; Harrison P; Doncel GF Sex Transm Dis; 2009 Mar; 36(3 Suppl):S76-80. PubMed ID: 19218888 [TBL] [Abstract][Full Text] [Related]
12. OMICS-driven biomarker discovery in nutrition and health. Kussmann M; Raymond F; Affolter M J Biotechnol; 2006 Aug; 124(4):758-87. PubMed ID: 16600411 [TBL] [Abstract][Full Text] [Related]
13. Clinical proteomics: the promises and challenges of mass spectrometry-based biomarker discovery. deVera IE; Katz JE; Agus DB Clin Adv Hematol Oncol; 2006 Jul; 4(7):541-9. PubMed ID: 17147241 [TBL] [Abstract][Full Text] [Related]
14. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics. Phan JH; Quo CF; Wang MD Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692 [TBL] [Abstract][Full Text] [Related]
15. Biomarker discovery by proteomics: challenges not only for the analytical chemist. Horvatovich P; Govorukhina N; Bischoff R Analyst; 2006 Nov; 131(11):1193-6. PubMed ID: 17066185 [TBL] [Abstract][Full Text] [Related]
16. High-performance proteomics as a tool in biomarker discovery. Meyer HE; Stühler K Proteomics; 2007 Sep; 7 Suppl 1():18-26. PubMed ID: 17893859 [TBL] [Abstract][Full Text] [Related]